ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

RNA Avidity Biosciences Inc

24.36
0.53 (2.22%)
Apr 26 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 1,034,630
Bid Price 23.71
Ask Price 25.88
News -
Day High 24.76

Low
4.825

52 Week Range

High
27.66

Day Low 23.49
Company Name Stock Ticker Symbol Market Type
Avidity Biosciences Inc RNA NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.53 2.22% 24.36 20:00:00
Open Price Low Price High Price Close Price Prev Close
24.01 23.49 24.76 24.36 23.83
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
11,485 1,034,630 $ 24.15 $ 24,985,817 - 4.825 - 27.66
Last Trade Time Type Quantity Stock Price Currency
17:12:14 1 $ 24.40 USD

Avidity Biosciences Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
1.94B 79.72M - 9.56M -212.22M -2.66 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Avidity Biosciences News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No RNA Message Board. Create One! See More Posts on RNA Message Board See More Message Board Posts

Historical RNA Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week22.8926.0222.2424.05911,6681.476.42%
1 Month25.5527.6621.5624.59952,191-1.19-4.66%
3 Months12.0327.6611.2320.921,167,39212.33102.49%
6 Months5.1127.664.82513.641,286,72919.25376.71%
1 Year16.8727.664.82512.011,146,4017.4944.40%
3 Years22.9029.594.82515.39785,5561.466.38%
5 Years26.5037.464.82516.43665,952-2.14-8.08%

Avidity Biosciences Description

Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product candidate AOC 1001, is designed to treat a rare monogenic muscle disease.

Your Recent History

Delayed Upgrade Clock